Galectin-3 Is a Potential Mediator for Atherosclerosis

Journal of Immunology Research - Egypt
doi 10.1155/2020/5284728
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Hindawi Limited

Related search

PECAM-1 Is a Critical Mediator of Atherosclerosis

DMM Disease Models and Mechanisms
ImmunologyMolecular BiologyBiochemistryMicrobiology NeuroscienceMedicineGenetics
2008English

Galectin-3 as a Potential Target to Prevent Cancer Metastasis

Clinical Medicine Insights: Oncology
Oncology
2015English

Galectin-3

Science-Business eXchange
2010English

Galectin-3

2017English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2015English

Galectin-3 Is Associated With a Poor Prognosis in Primary Hepatocellular Carcinoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2014English

Correction: Galectin-3 as a Marker and Potential Therapeutic Target in Breast Cancer

PLoS ONE
Multidisciplinary
2020English

Galectin-3 Is Associated With Restrictive Lung Disease and Interstitial Lung Abnormalities

American Journal of Respiratory and Critical Care Medicine
PulmonaryCritical CareRespiratory MedicineIntensive Care Medicine
2016English

Follistatin-Like 3 Is a Mediator of Exercise-Driven Bone Formation and Strengthening

Bone
EndocrinologyPhysiologyHistologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy